Chinese Alzheimer's drug market to grow by 20%-30%

Press Release   •   Feb 27, 2013 09:44 GMT

The Chinese Alzheimer's drug market has been forecast to increase by almost 24.5% over 2011, to reach a value of approximately CNY 20.03 billion by the end of 2012.

This increase is expected to continue at a rapid rate over the next few years, and the China Alzheimer's drugs market is forecast to grow by between 20%-30% in the coming years. Alzheimer's is predicted to affect 1 in 85 people globally by 2050.

Alzheimer's disease (AD), also known in medical literature as Alzheimer disease, is the most common form of dementia. There is no cure for the disease, which worsens as it progresses, and eventually leads to death.

It was first described by German psychiatrist and neuropathologist Alois Alzheimer in 1906 and was named after him. Most often, AD is diagnosed in people over 65 years of age, although the less-prevalent early-onset Alzheimer's can occur much earlier.

By the end of 2011, people aged 60 and above reached 185 million in China, accounting for 13.7% of the population, with an increase of 0.47 percentage point compared with that at the end of 2010.

The elderly population in China will exceed 200 million by the end of 2013 and reach 221 million in 2015, accounting for 16% of the population, with a severe population aging trend.

In China, AD often occurs to people aged over 65, accounting for about 4% to 5% of population in this age group, with nearly 10% of people aged over 75 and around 20% of people aged above 85.

It indicates that the morbidity rate of AD doubles with each 10-year-old increase in the age of the elderly.

Though the overall market size of senile disease drugs annually is huge in China, the market size of therapeutic AD drugs is still relatively small.

In 2011, the top 5 in China's hospital-use anti-AD drug market were Ganglioside, Gginkgo Biloba Preparations, Oxiracetam, Deproteinized Calf Blood Extracts and Edaravone, which aggregately accounted for 70% of the market share.

For more information on the Chinese Alzheimer's drug market, see the latest research: Chinese Alzheimer's Drug Market

Follow us on Twitter @CandMResearch issues news updates and report summaries covering all major industries and sectors. The service provides additional client monitoring and timely alerts to breaking industry and sector news leading the day's business headlines. News articles, written by our staff, contain additional analyst insight, providing value added insight for our readers. News updates and real-time alerts on newly-released market reports are also available from our Facebook page, Twitter feed @CandMResearch and RSS links. We also welcome inquiries from business journalists and the news media.